Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans
Appl Environ Microbiol 78:16
45 Products that are a combination of a DPP-4 inhibitor and an SGLT2 inhibitor (sitagliptin/ertugliflozin, saxagliptin/dapagliflozin, and linagliptin/empagliflozin) may be used to further lower A1C and provide increased CV benefit in patients who are not meeting A1C goals on dual therapy
[3] [4] If the actual supplied form is the acetate salt, use the corresponding salt-form CAS number and account for the counterion mass in concentration calculations
US$ 20.15
US$ 26.46
US$ 22.53
US$ 21.43
US$ 26.94
US$ 29.64
US$ 24.50
US$ 29.37
US$ 25.95
